UBS ASSET MANAGEMENT AMERICAS LLC - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$171,325,000
-33.6%
18,226
-45.9%
0.00%
Q2 2020$257,867,000
-1.2%
33,708
-20.2%
0.00%
Q1 2020$260,951,000
-50.3%
42,225
-2.1%
0.00%
Q4 2019$525,088,000
+10.7%
43,146
+5.1%
0.00%
Q3 2019$474,266,000
+76.0%
41,062
+52.2%
0.00%
Q2 2019$269,480,000
+72.9%
26,975
+123.0%
0.00%
Q1 2019$155,835,000
-15.2%
12,0990.0%0.00%
Q4 2018$183,784,000
-24.0%
12,0990.0%0.00%
Q3 2018$241,980,000
+2.6%
12,0990.0%0.00%
Q2 2018$235,931,000
-3.2%
12,0990.0%0.00%
Q1 2018$243,795,000
+85442.1%
12,099
+47.6%
0.00%
Q4 2016$285,000
-30.1%
8,199
-50.8%
0.00%
Q3 2016$408,000
+2.5%
16,6560.0%0.00%
Q2 2016$398,000
+26.3%
16,656
+23.8%
0.00%
Q1 2016$315,000
-26.7%
13,456
-5.6%
0.00%
Q4 2015$430,000
-24.0%
14,2560.0%0.00%
-100.0%
Q3 2015$566,000
-24.1%
14,256
+32.0%
0.00%0.0%
Q2 2015$746,000
+58.7%
10,799
+25.6%
0.00%
Q1 2015$470,000
+75.4%
8,599
+36.5%
0.00%
Q4 2014$268,000
+33.3%
6,2990.0%0.00%
Q3 2014$201,0006,2990.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Bleichroeder LP 1,299,994$12,220,0002.19%
Camber Capital Management LP 8,780,000$82,532,0002.18%
Palo Alto Investors LP 3,003,875$28,236,0001.55%
ARMISTICE CAPITAL, LLC 4,120,000$38,728,0001.40%
Permanens Capital L.P. 359,311$3,378,0001.17%
IRONWOOD INVESTMENT MANAGEMENT LLC 31,582$297,0000.21%
BOOTHBAY FUND MANAGEMENT, LLC 348,000$3,271,0000.20%
Teza Capital Management LLC 20,300$191,0000.11%
JACOBS LEVY EQUITY MANAGEMENT, INC 767,135$7,211,0000.08%
Livforsakringsbolaget Skandia, Omsesidigt 38,800$365,0000.04%
View complete list of AMAG PHARMACEUTICALS INC shareholders